We only have this paper's title and publication details.
Read it at the sourceDeletion of SPPL3 sheddase enhances CAR T cell persistence in allogeneic settings, suggesting improved efficacy in cell therapies.
Deletion of the SPPL3 sheddase improves allogeneic CAR T cell persistence.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: